Evidence map›Paper›PMID 31893090›Full record

ArticleClinical case reports2019

Head and neck neuroendocrine tumors at a single institution over 15 years.

Maria Bacalao, Muhammad S Beg, Dominick Cavuoti, Hong Zhu, Baran Sumer, Larry Myers, John Truelson, Lucien Nedzi, David Sher, Randall Hughes and 1 more

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Neuroendocrine Carcinoma of the Head and Neck: A Two-Decade Institutional Experience.World journal of otorhinolaryngology - head and neck surgery · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maria BacalaoDepartment of Medicine UT Southwestern Medical Center Dallas Texas.
Muhammad S BegDivision of Hematology and Oncology/Harold C. Simmons Comprehensive Cancer Center UT Southwestern Medical Center Dallas Texas.
Dominick CavuotiDepartment of Pathology UT Southwestern Medical Center Dallas Texas.
Hong ZhuDepartment of Clinical Sciences UT Southwestern Medical Center Dallas Texas.
Baran SumerDepartment of Otolaryngology UT Southwestern Medical Center Dallas Texas.
Larry MyersDepartment of Otolaryngology UT Southwestern Medical Center Dallas Texas.
John TruelsonDepartment of Otolaryngology UT Southwestern Medical Center Dallas Texas.
Lucien NedziDepartment of Radiation Oncology UT Southwestern Medical Center Dallas Texas.
David SherDepartment of Radiation Oncology UT Southwestern Medical Center Dallas Texas.
Randall HughesDivision of Hematology and Oncology/Harold C. Simmons Comprehensive Cancer Center UT Southwestern Medical Center Dallas Texas.
Saad A KhanDivision of Hematology and Oncology/Harold C. Simmons Comprehensive Cancer Center UT Southwestern Medical Center Dallas Texas.ORCID https://orcid.org/0000-0002-3440-9774

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Head and neck cancer is a diverse group of rare diseases such as neuroendocrine tumors which can be thought of as extrapulmonary small-cell cancer. Surgery, chemotherapy, and radiation can frequently cure this disease, possibly due to early detection.

Indexed as

head and neck cancerlarynx cancerneuroendocrine cancer

Identifiers

PMID31893090
PMCPMC6935626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.